Lars Hanker - Department of Obstetrics and Gynecology, Goethe University

基本信息

浏览量：92

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 303 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Prognostic and Clinical Heterogeneity of PD1 and PD-L1- Immunohistochemical Scores in Endometrial Cancers

L. Proppe,T. Jagomast,S. Beume, F. Köster,K. Bräutigam, A. Rody, S. Perner, F. Hemptenmacher,J. Ribbat-Idel,L. C. Hanker

Archives of Gynecology and Obstetricspp.1-11, (2025)

引用0浏览0WOS引用

Minimally Invasive Compared to Open Surgery in Patients with Low-Risk Cervical Cancer Following Simple Hysterectomy: an Exploratory Analysis from the GCIG/CCTG CX.5/SHAPE Trial

Marie Plante,Sven Mahner,Alexandra Sebastianelli,Paul Bessette,Eric Lambaudie,Frederic Guyon,Jurgen Piek, Ramon Smolders,John Tidy,Karin Williamson,Lars Hanker,Frederic Goffin,Irina Tsibulak,Brynhildur Eyjolfsdottir,Noreen Gleeson,Jung-Yun Lee, Yuwei Ke,Janice S. Kwon,Sarah E. Ferguson,Lois Shepherd

International Journal of Gynecological Cancerpp.100001, (2024)

引用0浏览0引用

Real World Qualitätssicherungsdaten Beim Frühen Ovarialkarzinom: Ergebnisse Der QS-Ovar

P. Wimberger,J. Pfisterer,A. du Bois,F. Hilpert,M. Kerkmann,J. Sehouli,S. Mahner,N. de Gregorio,L. Hanker,F. Heitz,F. Marmé,L. Wölber,L. Holtmann,G. Elser,P. Harter

Geburtshilfe und Frauenheilkunde 65 Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e V (2024)

引用0浏览0引用

803 Efficacy and Safety of Bevacizumab Following Prior Anti-Angiogenic Treatment in Patients with Second-Line Platinum- Based Chemotherapy in Recurrent Ovarian Cancer – a Subgroup Analysis of the AGO-OVAR 2.21 Phase III Trial

Anca Chelariu-Raiciu,Fabian Trillsch,Phillip Harter, Ralf Strobl,Jalid Sehouli,Pauline Wimberger,Holger Bronger,Catherine Shannon,Claudia Lefeuvre,Joern Rau,Lars Hanker,Stephan Polterauer,Frederik Marmé,Ahmed El-Balat,Martin R. Stockler,Nikolaus De Gregorio,Ros Glasspool,Sven Mahner,Alain Lortholary,Jacobus Pfisterer

International Journal of Gynecological Cancer (2024): A38-A39

引用1浏览0引用

Bevacizumab after Prior Anti-Angiogenic Treatment in Female Patients with Platinum-Based Chemotherapy in Second-line Treatment of Recurrent Ovarian Cancer - A Subgroup Analysis of Efficacy and Safety in AGOOVAR 2.21

A. Chelariu-Raicu,F. Trillsch,P. Harter, R. Strobl,J. Sehouli,P. Wimberger,H. Bronger, S. Catherine, C. Lefeuvre,J. Rau,L. Hanker, P. Edgar,F. Heitz,F. Marme, A. El-Balat,M. Stockler,N. de Gregorio,R. Glasspool,S. Mahner,A. Lortholary,J. Pfisterer

GEBURTSHILFE UND FRAUENHEILKUNDEno. 6 (2024): E44-E45

引用0浏览0引用

38MO Progression-free Survival (PFS) in Primary Advanced or Recurrent Endometrial Cancer (pa/rec) in the Overall and Mismatch Repair Proficient (MMR/MSS) Populations and in Histological and Molecular Subgroups: Results from Part 2 of the RUBY Trial

M.R. Mirza,S. Ghamande,L.C. Hanker,D. Black, N. Raaschou-Jensen,L. Gilbert,A. Oaknin,A.A. Secord,A. Savarese,R.W. Holloway,R. Kristeleit,J. Buscema,I.A. Boere,S. Sharma,C. Gennigens,P. Ghatage, K. Yablonski, S. Stevens, H. Trukhan,M.A. Powell

ESMO Open（2024）

引用0浏览0引用

469 Angiogenesis Gene Variants As Biomarkers for Bevacizumab-Induced Toxicities: a Translational Subproject of the Prospective Randomized Phase III Trial AGO-OVAR 17

Rahel Polaczek,Florian Heitz,Dhanya Ramachandran,Peter Hillemanns,Jörn Rau,Philipp Harter,Martin L. Heubner,Ulrich Canzler,Christian Jackisch,Klaus Baumann,Barbara Schmalfeldt,Alexander Burges,Lars Ch Hanker,Andreas D. Hartkopf,Tjoung-Won Park-Simon,Antje Belau,Dominik Denschlag,Willibald Schröder,Thilo Dörk,Jacobus Pfisterer

International Journal of Gynecological Cancer (2024): A497

引用0浏览0引用

Treatment and Outcome of Patients with High-Grade Advanced Ovarian Cancer (AOC): Real-world Data in Germany (QS Ovar of the AGO Study Group)

Sven Mahner,Philipp Harter,Andreas Du Bois,Felix Hilpert,Markus Kerkmann,Jalid Sehouli,Nikolaus de Gregorio,Lars Ch. Hanker,Florian Heitz,Frederik Marme,Linn Lena Woelber,Laura Holtmann,Gabriele Elser,Jacobus Pfisterer

ESMO Open (2024): 103579-103579

引用1浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn